Trials / Completed
CompletedNCT00758784
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bromfenac ophthalmic solution 0.06% | bromfenac ophthalmic solution 0.06% bilaterally twice a day |
Timeline
- Start date
- 2008-08-13
- Primary completion
- 2009-01-14
- Completion
- 2009-01-14
- First posted
- 2008-09-25
- Last updated
- 2020-09-14
- Results posted
- 2020-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00758784. Inclusion in this directory is not an endorsement.